71125-44-5

Basic information

• Product Name: 5-MORPHOLIN-4-YL-1,3,4-THIADIAZOL-2-AMINE
• Synonyms: 5-MORPHOLIN-4-YL-1,3,4-THIADIAZOL-2-AMINE;TOSLAB 5894;5-Morpholin-4-yl-1,3,4-thiadazaol-2-amine;5-Morpholino-1,3,4-thiadiazol-2-amine
• CAS NO: 71125-44-5
• Molecular Formula: C₆H₁₀N₄OS
• Molecular Weight: 186.23
• Mol File: 71125-44-5.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 373.9±52.0 °C(Predicted)
• Appearance: /
• Density: 1.422±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C(protect from light)
• PKA: 5.55±0.10(Predicted)
• CAS DataBase Reference: 5-MORPHOLIN-4-YL-1,3,4-THIADIAZOL-2-AMINE(CAS DataBase Reference)
• NIST Chemistry Reference: 5-MORPHOLIN-4-YL-1,3,4-THIADIAZOL-2-AMINE(71125-44-5)
• EPA Substance Registry System: 5-MORPHOLIN-4-YL-1,3,4-THIADIAZOL-2-AMINE(71125-44-5)

Safety Data

• Hazardous Substances Data: 71125-44-5(Hazardous Substances Data)

Usage

General Description

5-MORPHOLIN-4-YL-1,3,4-THIADIAZOL-2-AMINE is a chemical compound that consists of a morpholinyl group attached to a 1,3,4-thiadiazol-2-amine structure. It is a heterocyclic compound with potential pharmaceutical applications due to its diverse biological activities. The morpholine moiety is a six-membered heterocycle containing an oxygen and nitrogen atom, while the thiadiazole ring consists of a five-membered ring with two nitrogen and one sulfur atom. 5-MORPHOLIN-4-YL-1,3,4-THIADIAZOL-2-AMINE may have potential as a therapeutic agent in the treatment of various diseases due to its unique chemical structure and potential biological activities. However, further research is needed to explore its full pharmacological potential and possible applications in the pharmaceutical industry.

Upstream product

• 110-91-8 morpholine 
• 37566-39-5 5-bromo-2-amino-1,3,4-thiadiazole 

Relevant articles and documents

1,3,4-THIADIAZOLES USEFUL FOR THE TREATMENT OF CMV INFECTIONS

The present invention presents novel 1,3,4-thiadiazole derivatives of formula I which have useful antiviral activity against herpes virus, cytomegalovirus (CMV).

7H-1,3,4-Thiadiazolo-[3,2-a]-pyrimidin-7-one-5-carboxylic compounds

Derivatives of 7H-1,3,4-thiadiazolo-[3,2-a]-pyrimidin-7-one-5-carboxylic acid having basic substituents in the 2-position, the alkyl esters and/or pharmaceutically useable salts of these compounds are new substances having immunstimulating properties, being especially valuable for antiinfectious therapy in mammals including man. The new products are prepared by reacting 2-amino-5-(basically substituted)-1,3,4-thiadiazoles with dialkylacetylenedicarboxylates and splitting the ester grouping in the obtained compound if desired and/or forming pharmaceutically acceptable salts.